Salha Bujassoum

Preference for the fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in patients with HER2-positive early breast cancer (PHranceSCa): A randomised, open-label phase II study

Joyce O’Shaughnessy, Susana Sousa, Josefina Cruz et al. · European Journal of Cancer · 2021 · 74 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Isolated Central Nervous System Relapse in Lymphoid Blast Crisis Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia in Patients on Imatinib Therapy

Salha Bujassoum, Joshua Rifkind, Jeffrey H. Lipton · Leukemia & lymphoma/Leukemia and lymphoma · 2003 · 54 citations

Medicine, Hematology, Oncology +15

Genotype and Phenotype Correlation of Breast Cancer in BRCA Mutation Carriers and Non-Carriers

Salha Bujassoum, Hekmet Bugrein, Reem Al Sulaiman · Journal of Cancer Science & Therapy · 2017 · 22 citations

Life Sciences, Genetics, Oncology +17

Applying value-based strategies to accelerate access to novel cancer medications: guidance from the Oncology Health Economics Expert Panel in Qatar (Q-OHEP)

Anas Hamad, Shereen Elazzazy, Salha Bujassoum et al. · BMC Health Services Research · 2023 · 11 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17